
Cinacalcet Hydrochloride
Form: Tablet
Strength: 30 mg 60 mg 90 mg
Reference Brands: Sensipar,Cinacalcet (EU & US)
Category: Nephrology
Cinacalcet Hydrochloride Tablets are a calcimimetic medication used to treat secondary hyperparathyroidism in chronic kidney disease (CKD) patients, particularly those on dialysis. By increasing the sensitivity of calcium-sensing receptors, Cinacalcet helps regulate parathyroid hormone (PTH) levels, improving calcium and phosphate balance. It is essential for managing bone disease and reducing the risk of vascular calcification in dialysis-dependent patients. Available for B2B distribution in the US and EU, Cinacalcet Hydrochloride offers a vital therapeutic solution for nephrology, providing effective management of hyperparathyroidism and contributing to improved outcomes in CKD patients.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Calcitriol
Strength: Capsules:0.25 mcg, 0.5 mcg; Injection:1 mcg/mL
Form: Capsules & Injection
Reference Brands: Rocaltrol®(EU & US), Calcijex® (US)
View DetailsParicalcitol Generics
Strength: Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL
Form: Capsules and Injection
Reference Brands: Zemplar®(US &EU)
View DetailsMethoxy Polyethylene Glycol-Epoetin Beta Generics
Strength: 25–250 mcg
Form: Solution for Injection
Reference Brands: Mircera® (US &EU)
View Details